Nomura Holdings, Inc. (NMR) Stock Forecast
Data as of Sep 20, 2026Financial Services · Current price $10.07 (-1.52%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
NMR vs Sector & Market
| Metric | NMR | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.52 | 2.42 |
| Analyst Count | 1 | 9 | 18 |
| Target Upside | +1.2% | +87.7% | +21.5% |
| P/E Ratio | 10.21 | -4.72 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $3.51B | $3.51B | $3.51B | 1 |
| 2026-12-31 | $3.55B | $3.55B | $3.55B | 1 |
| 2027-03-31 | $3.59B | $3.59B | $3.59B | 1 |
| 2027-06-30 | $3.60B | $3.60B | $3.60B | 1 |
| 2027-09-30 | $3.63B | $3.63B | $3.63B | 1 |
| 2027-12-31 | $3.67B | $3.67B | $3.67B | 1 |
| 2028-03-31 | $3.71B | $3.71B | $3.71B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.20 | $0.20 | $0.20 | 1 |
| 2026-12-31 | $0.20 | $0.20 | $0.20 | 1 |
| 2027-03-31 | $0.22 | $0.22 | $0.22 | 1 |
| 2027-06-30 | $0.22 | $0.22 | $0.22 | 1 |
| 2027-09-30 | $0.23 | $0.23 | $0.23 | 1 |
| 2027-12-31 | $0.23 | $0.23 | $0.23 | 1 |
| 2028-03-31 | $0.24 | $0.24 | $0.24 | 1 |
Frequently Asked Questions
What is the analyst consensus for NMR?
The consensus among 1 analysts covering Nomura Holdings, Inc. (NMR) is Buy with an average price target of $10.20.
What is the highest price target for NMR?
The highest analyst price target for NMR is $10.20.
What is the lowest price target for NMR?
The lowest analyst price target for NMR is $10.20.
How many analysts cover NMR?
1 analysts have issued ratings for Nomura Holdings, Inc. in the past 12 months.
Is NMR a buy or sell right now?
Based on 1 analyst ratings, NMR has a consensus rating of Buy (2.00/5) with a +1.2% upside to the consensus target of $10.20.
What are the earnings estimates for NMR?
Analysts estimate NMR will report EPS of $0.20 for the period ending 2026-09-30, with revenue estimated at $3.51B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.